Correlation Between Alzinova and AlzeCure Pharma

Can any of the company-specific risk be diversified away by investing in both Alzinova and AlzeCure Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alzinova and AlzeCure Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Alzinova AB and AlzeCure Pharma, you can compare the effects of market volatilities on Alzinova and AlzeCure Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alzinova with a short position of AlzeCure Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alzinova and AlzeCure Pharma.

Diversification Opportunities for Alzinova and AlzeCure Pharma

-0.67

Correlation Coefficient

Alzinova  AlzeCure Pharma

Excellent diversification

The 3 months correlation between Alzinova and AlzeCure is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Alzinova AB and AlzeCure Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AlzeCure Pharma and Alzinova is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alzinova AB are associated (or correlated) with AlzeCure Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AlzeCure Pharma has no effect on the direction of Alzinova i.e., Alzinova and AlzeCure Pharma go up and down completely randomly.

Pair Corralation between Alzinova and AlzeCure Pharma

Assuming the 90 days trading horizon Alzinova AB is expected to under-perform the AlzeCure Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Alzinova AB is 3.32 times less risky than AlzeCure Pharma. The stock trades about -0.14 of its potential returns per unit of risk. The AlzeCure Pharma is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest  117.00  in AlzeCure Pharma on December 24, 2024 and sell it today you would earn a total of  163.00  from holding AlzeCure Pharma or generate 139.32% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Alzinova AB  vs.  AlzeCure Pharma

Alzinova AB

Risk-Adjusted Performance

Very Weak

Over the last 90 days Alzinova AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

AlzeCure Pharma

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in AlzeCure Pharma are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, AlzeCure Pharma sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Alzinova and AlzeCure Pharma

The main advantage of trading using opposite Alzinova and AlzeCure Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alzinova position performs unexpectedly, AlzeCure Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AlzeCure Pharma will offset losses from the drop in AlzeCure Pharma's long position.

The idea behind Alzinova AB and AlzeCure Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.